Venture-Backed Startups

0 investors

0 investors

0 investors

0 investors

Acuity operates a crowdsourced platform that collects and annotates first-person and multi-view video data of people performing real-world tasks, using a smartphone app and contributor network. It supplies large-scale, quality-controlled demonstration datasets for embodied AI and robotics teams training vision-language-action models and manipulation policies.

1 investor

1 investor

A pharmaceutical company focused on supplying medicines and improving access to high-quality drugs, offering branded originator drugs, authorized generics, complex generics, and other generic medicines. It operates globally with expertise in science, medical, and manufacturing, and this page covers its Japan product offerings.

2 investors

0 investors

Acumatica provides all-in-one cloud ERP software with industry-specific solutions covering business workflows, dashboards, reporting, and mobile access. Its platform includes AI/ML automation and low-code/no-code customization tools aimed at growing companies and their developers and business users.

3 investors

Acumen is a global venture philanthropy organization that deploys capital to high-innovation enterprises addressing poverty in agriculture, energy, education, healthcare, and employment across Africa, South Asia, Southeast Asia, Latin America, and the United States. It invests in social entrepreneurs and mission-driven founders working to break cycles of poverty through climate-resilient practices, clean energy infrastructure, and job market preparation.

1 investor

A high-growth internet retailer operating a dozen online specialty shops offering merchandise across a variety of categories.

3 investors

Acumen Sports and Shoulder provides orthopedic surgical care and sports medicine services, including injury assessment, rehabilitation, and performance training for athletes. The company serves competitive and recreational athletes through certified athletic therapists and surgeons specializing in musculoskeletal injury management.

1 investor

Acumen Pharmaceuticals is developing treatments for Alzheimer's disease and other neurodegenerative diseases, focusing on understanding and targeting amyloid beta oligomers in neurodegeneration.

2 investors

Acumen Public Affairs is an independent public affairs and policy communications consultancy that advises clients on regulatory, political, and strategic challenges. The firm combines policy expertise with specialized talent in digital strategy, communications, and technical analysis, serving clients at national, European, and international levels.

1 investor

Acumentrics designs and integrates power solutions for customers across various applications, emphasizing technical expertise and long-term customer relationships throughout the project lifecycle.

1 investor

0 investors

Physical AI for industrial automation

3 investors

Acunote is a software company based in San Francisco.

1 investor

Acura is a dental service organization operating a network of around 100 dental practices in Germany, handling administrative tasks, organization, and modern equipment so dentists can focus on patient care. It offers practice acquisition and employment options for dentists seeking to hand over or join a practice group.

1 investor

1 investor

Acurable manufactures wearable acoustic sensor devices for home-based patient monitoring and chronic disease management. The AcuPebble product family uses signal processing to extract disease-related biomarkers for diagnostic and disease management purposes.

5 investors

AcuraStem is a biotechnology company developing antisense oligonucleotide treatments for neurodegenerative diseases such as ALS and frontotemporal dementia, using its iNeuroRx technology platform for disease modeling and drug discovery. It targets PIKFYVE, discovered by its co-founders, to advance a pipeline of therapies.

2 investors

Acurion Health develops OncoGaze, a technology that predicts clinically actionable genomic biomarkers from routine digital histology tissue slides at the biopsy stage. It serves oncologists by identifying morphological patterns in tissue images to speed up biomarker screening and guide precision cancer therapy.

1 investor

0 investors